Recombinant Human DESI1 Protein，His

DESI1, or desumoylating isopeptidase 1, is a member of the isopeptidase family that plays a crucial role in the regulation of SUMO (Small Ubiquitin-like Modifier) protein modifications. These modifications are essential for various cellular processes, including signal transduction, DNA repair, and the regulation of gene expression. The study of DESI1 has gained significant attention due to its involvement in various diseases, particularly cancer, where altered SUMOylation patterns can lead to tumorigenesis and cancer progression. The ability of DESI1 to remove SUMO moieties from target proteins suggests that it acts as a regulatory switch, impacting protein function and cellular signaling pathways. Moreover, understanding the specific substrates of DESI1 and its mechanism of action could uncover potential therapeutic targets for SUMO-related diseases. Recent advances in structural biology have enabled researchers to characterize DESI1 at the molecular level, providing insights into its enzymatic activity and substrate recognition. The investigation of DESI1 not only enhances our understanding of the SUMO pathway but also contributes to the broader field of post-translational modifications, which are critical for maintaining cellular homeostasis and function. Consequently, the research on DESI1 recombinant protein has significant implications for developing innovative strategies to manipulate SUMOylation in disease contexts and offers potential avenues for novel therapeutic interventions.